• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过相转移催化获得的香草基乳糖的 3′-选择性硫酸酯化合成半乳糖凝集素抑制剂。

Synthesis of Galectin Inhibitors by Regioselective 3'--Sulfation of Vanillin Lactosides Obtained under Phase Transfer Catalysis.

机构信息

Department of Chemistry, University of Québec à Montréal, P.O. Box 8888, Succ. Centre-Ville, Montréal, QC H3C 3P8, Canada.

INRS-Institut Armand-Frappier, Université du Québec, 531 boul. des Prairies, Laval, QC H7V 1B7, Canada.

出版信息

Molecules. 2020 Dec 29;26(1):115. doi: 10.3390/molecules26010115.

DOI:10.3390/molecules26010115
PMID:33383774
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7795656/
Abstract

Vanillin-based lactoside derivatives were synthetized using phase-transfer catalyzed reactions from per--acetylated lactosyl bromide. The aldehyde group of the vanillin moiety was then modified to generate a series of related analogs having variable functionalities in the position of the aromatic residue. The corresponding unprotected lactosides, obtained by Zemplén transesterification, were regioselectively 3'--sulfated using tin chemistry activation followed by treatment with sulfur trioxide-trimethylamine complex (MenN-SO). Additional derivatives were also prepared from the vanillin's aldehyde using a Knoevenagel reaction to provide extended α, β-unsaturated carboxylic acid which was next reduced to the saturated counterpart.

摘要

采用相转移催化反应,从全乙酰化乳酰溴合成了基于香草醛的乳糖苷衍生物。然后修饰香草醛部分的醛基,生成一系列在芳基残基的 位具有可变官能团的相关类似物。通过 Zemplén 酯交换获得的相应非保护的乳糖苷,通过锡化学活化进行选择性 3'-硫酸化,然后用三氧化硫-三甲胺复合物(MenN-SO)处理。还可以使用 Knoevenagel 反应从香草醛的醛基制备其他衍生物,以提供扩展的α,β-不饱和羧酸,然后将其还原为相应的饱和羧酸。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b15/7795656/45a548753f45/molecules-26-00115-sch003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b15/7795656/e23c5cbc261a/molecules-26-00115-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b15/7795656/d584586fda7a/molecules-26-00115-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b15/7795656/0650471c2d9f/molecules-26-00115-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b15/7795656/45a548753f45/molecules-26-00115-sch003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b15/7795656/e23c5cbc261a/molecules-26-00115-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b15/7795656/d584586fda7a/molecules-26-00115-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b15/7795656/0650471c2d9f/molecules-26-00115-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b15/7795656/45a548753f45/molecules-26-00115-sch003.jpg

相似文献

1
Synthesis of Galectin Inhibitors by Regioselective 3'--Sulfation of Vanillin Lactosides Obtained under Phase Transfer Catalysis.通过相转移催化获得的香草基乳糖的 3′-选择性硫酸酯化合成半乳糖凝集素抑制剂。
Molecules. 2020 Dec 29;26(1):115. doi: 10.3390/molecules26010115.
2
Defining the potential of aglycone modifications for affinity/selectivity enhancement against medically relevant lectins: synthesis, activity screening, and HSQC-based NMR analysis.定义糖苷配基修饰对医学相关凝集素亲和力/选择性增强的潜力:合成、活性筛选及基于HSQC的核磁共振分析
Chembiochem. 2015 Jan 2;16(1):126-39. doi: 10.1002/cbic.201402474. Epub 2014 Nov 18.
3
Synthesis of regioselectively sulfated xylodextrins and crystal structure of sodium methyl beta-D-xylopyranoside 4-O-sulfate hemihydrate.区域选择性硫酸化木糖糊精的合成及β-D-吡喃木糖苷4-O-硫酸甲酯半水合物钠的晶体结构
Carbohydr Res. 2009 Jan 5;344(1):21-8. doi: 10.1016/j.carres.2008.09.018. Epub 2008 Sep 24.
4
Synthesis of stable and selective inhibitors of human galectins-1 and -3.人半乳糖凝集素-1和-3的稳定且具选择性的抑制剂的合成。
Bioorg Med Chem. 2008 Aug 15;16(16):7811-23. doi: 10.1016/j.bmc.2008.06.044. Epub 2008 Jun 26.
5
Synthesis of bivalent lactosides based on terephthalamide, N,N'-diglucosylterephthalamide, and glycophane scaffolds and assessment of their inhibitory capacity on medically relevant lectins.基于对苯二甲酰胺、N,N'-二葡萄糖基对苯二甲酰胺和甘宝素支架的二价乳糖的合成及其对医学相关凝集素抑制能力的评估。
J Org Chem. 2009 Dec 4;74(23):9010-26. doi: 10.1021/jo901667r.
6
Synthesis and evaluation of iminocoumaryl and coumaryl derivatized glycosides as galectin antagonists.亚氨基香豆素基和香豆素基衍生化糖苷作为半乳糖凝集素拮抗剂的合成与评价
Bioorg Med Chem Lett. 2014 Aug 1;24(15):3516-20. doi: 10.1016/j.bmcl.2014.05.063. Epub 2014 Jun 9.
7
Aryl O- and S-galactosides and lactosides as specific inhibitors of human galectins-1 and -3: role of electrostatic potential at O-3.芳基O-和S-半乳糖苷及乳糖苷作为人半乳糖凝集素-1和-3的特异性抑制剂:O-3位静电势的作用
Bioorg Med Chem Lett. 2006 Mar 15;16(6):1668-72. doi: 10.1016/j.bmcl.2005.12.010. Epub 2006 Jan 5.
8
Teaming up synthetic chemistry and histochemistry for activity screening in galectin-directed inhibitor design.在半乳糖凝集素导向的抑制剂设计中,将合成化学与组织化学相结合用于活性筛选。
Histochem Cell Biol. 2017 Feb;147(2):285-301. doi: 10.1007/s00418-016-1525-5. Epub 2016 Dec 24.
9
Facile synthesis of aminooxy glycosides by gold(III)-catalyzed glycosidation.通过金(III)催化的糖苷化反应简便合成氨氧基糖苷。
Carbohydr Res. 2016 Jul 22;430:16-23. doi: 10.1016/j.carres.2016.04.022. Epub 2016 Apr 27.
10
Click inspired synthesis of triazole-linked vanillin glycoconjugates.点击化学法合成三唑连接的香草醛糖缀合物。
Glycoconj J. 2017 Feb;34(1):61-70. doi: 10.1007/s10719-016-9729-4. Epub 2016 Oct 3.

引用本文的文献

1
Selectively Modified Lactose and -Acetyllactosamine Analogs at Three Key Positions to Afford Effective Galectin-3 Ligands.在三个关键位置选择性修饰乳糖和 -N-乙酰乳糖胺类似物,以提供有效的半乳糖凝集素-3 配体。
Int J Mol Sci. 2023 Feb 13;24(4):3718. doi: 10.3390/ijms24043718.
2
Recent Development in the Design of Neoglycoliposomes Bearing Arborescent Architectures.具有树状结构的糖基脂双层囊泡的设计新进展。
Molecules. 2021 Jul 15;26(14):4281. doi: 10.3390/molecules26144281.

本文引用的文献

1
Aromatic heterocycle galectin-1 interactions for selective single-digit nM affinity ligands.用于选择性单纳米摩尔亲和力配体的芳香杂环半乳糖凝集素-1相互作用
RSC Adv. 2018 Jul 11;8(44):24913-24922. doi: 10.1039/c8ra04389b. eCollection 2018 Jul 9.
2
Effects of linker and liposome anchoring on lactose-functionalized glycomacromolecules as multivalent ligands for binding galectin-3.连接体和脂质体锚定对乳糖功能化糖大分子作为结合半乳糖凝集素-3的多价配体的影响。
RSC Adv. 2019 Jul 29;9(41):23484-23497. doi: 10.1039/c9ra05497a.
3
Targeting Galectins With Glycomimetics.
用糖模拟物靶向半乳糖凝集素
Front Chem. 2020 Aug 7;8:593. doi: 10.3389/fchem.2020.00593. eCollection 2020.
4
Glycopolymers for Efficient Inhibition of Galectin-3: Proof of Efficacy Using Suppression of T Lymphocyte Apoptosis and Tumor Cell Migration.糖聚合物高效抑制半乳糖凝集素-3:抑制 T 淋巴细胞凋亡和肿瘤细胞迁移的疗效证明。
Biomacromolecules. 2020 Aug 10;21(8):3122-3133. doi: 10.1021/acs.biomac.0c00515. Epub 2020 Jul 22.
5
Antioxidant activity and polyphenol composition of sugarcane molasses extract.甘蔗蜜饯提取物的抗氧化活性和多酚组成。
Food Chem. 2020 Jun 1;314:126180. doi: 10.1016/j.foodchem.2020.126180. Epub 2020 Jan 11.
6
High-Affinity -(2-Hydroxypropyl)methacrylamide Copolymers with Tailored -Acetyllactosamine Presentation Discriminate between Galectins.高亲和性-(2-羟丙基)甲基丙烯酰胺共聚物,具有定制的乙酰乳糖胺呈现,可区分半乳糖凝集素。
Biomacromolecules. 2020 Feb 10;21(2):641-652. doi: 10.1021/acs.biomac.9b01370. Epub 2020 Jan 23.
7
Sweetening the hallmarks of cancer: Galectins as multifunctional mediators of tumor progression.甜蜜的癌症特征:半乳糖凝集素作为肿瘤进展的多功能介质。
J Exp Med. 2020 Feb 3;217(2). doi: 10.1084/jem.20182041.
8
: F-Radiolabeled Glycomimetics Allow Insights into the Pharmacological Fate of Galectin-3 Inhibitors.F-放射性标记的糖模拟物可深入了解半乳糖凝集素-3 抑制剂的药理命运。
J Med Chem. 2020 Jan 23;63(2):747-755. doi: 10.1021/acs.jmedchem.9b01692. Epub 2020 Jan 3.
9
An Orally Active Galectin-3 Antagonist Inhibits Lung Adenocarcinoma Growth and Augments Response to PD-L1 Blockade.一种口服活性半乳糖凝集素-3 拮抗剂抑制肺腺癌生长并增强对 PD-L1 阻断的反应。
Cancer Res. 2019 Apr 1;79(7):1480-1492. doi: 10.1158/0008-5472.CAN-18-2244. Epub 2019 Jan 23.
10
Chemoenzymatic Synthesis of Galectin Binding Glycopolymers.半合成糖聚合物及其与半乳凝素的相互作用
Bioconjug Chem. 2018 Dec 19;29(12):4030-4039. doi: 10.1021/acs.bioconjchem.8b00599. Epub 2018 Nov 14.